Literature DB >> 32646173

Sulfated Alginate as a Mimic of Sulfated Glycosaminoglycans: Binding of Growth Factors and Effect on Stem Cell Behavior.

Rami Mhanna1,2,3, Jana Becher4, Matthias Schnabelrauch4, Rui L Reis1,2, Iva Pashkuleva1,2.   

Abstract

Sulfated glycosaminoglycans (GAGs) are principal elements of the extracellular matrix, where they are involved in a plethora of signaling pathways mainly via interactions with diverse proteins such as growth factors and cytokines. However, the mechanisms that drive these interactions are not yet clear, mostly because of the difficulty to access large quantities of homogeneously sulfated natural GAGs. In this work, GAG mimics are synthesized from readily available alginate with different degrees of sulfation (DS, from 0.8 to 2.6) by simple process. The effect of the DS is determined on the binding of basic fibroblast growth factor (FGF-2). The enzyme-linked immunosorbent assay demonstrates that the binding of FGF-2 is significantly greater for alginates with high DS as compared to unmodified and low sulfated analogs. These results are further applied to engineer FGF-2-loaded substrates for stem cell culturing using the layer-by-layer approach. All films support the attachment and growth of adipose derived stem cells (ADSCs). Noteworthy, highly sulfated alginates maintain the stemness of the ADSCs that exhibit remarkably long filopodia. These results can be exploited in the engineering of novel substrates that induce targeted cell behavior via controlled protein delivery and for tissue engineering constructs applicable in various regenerative approaches.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alginate; biomimetic materials; growth factors; layer-by-layer; sulfated glycosaminoglycans

Year:  2017        PMID: 32646173     DOI: 10.1002/adbi.201700043

Source DB:  PubMed          Journal:  Adv Biosyst        ISSN: 2366-7478


  1 in total

1.  Engineered biomaterial strategies for controlling growth factors in tissue engineering.

Authors:  Na Guan; Zhihai Liu; Yonghui Zhao; Qiu Li; Yitao Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.